Related Experiment Video
Updated: Jul 24, 2026

09:16
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Published on: November 26, 2018
Production of tissue factor by monocyte progenitor cells
A C Stephens1, R Q Zheng, A R Russell
1Department of Paediatrics, St. Mary's Hospital, Paddington, London, UK.
Thrombosis Research
|October 1, 1994
Summary
Human monocyte progenitor cells from bone marrow produce tissue factor (TF). This finding reveals a new source of TF, crucial for understanding blood clotting and related diseases.
Area of Science:
- Hematology
- Immunology
- Molecular Biology
Background:
- Tissue factor (TF) is primarily known to be produced by monocytes in human peripheral blood.
- The production of TF by hematopoietic progenitor cells remains largely uncharacterized.
- Understanding TF production in early myeloid cells is critical for hemostasis and thrombosis research.
Purpose of the Study:
- To investigate the production of tissue factor (TF) by human monocyte progenitor cells.
- To determine if these progenitor cells exhibit procoagulant activity.
- To confirm the presence of TF and its messenger RNA (mRNA) in these cells.
Main Methods:
- Isolation of human monocyte progenitor cells from bone marrow of normal and diseased individuals.
- Characterization of cell properties including adherence and phagocytosis.
- Assessment of procoagulant activity using partial thromboplastin time clotting assays.
- Blocking of procoagulant activity with a neutralizing anti-TF monoclonal antibody (G12).
- Detection of TF mRNA using dot blot and northern blot analyses with an oligonucleotide probe.
Main Results:
- Isolated cells were non-adherent, monocytic, and capable of phagocytosis.
- Unactivated progenitor cells demonstrated procoagulant activity, indicative of TF function.
- This activity was specifically inhibited by the anti-TF monoclonal antibody G12.
- TF messenger RNA was successfully detected in these cells via molecular analyses.
Conclusions:
- Human monocyte progenitor cells isolated from bone marrow are capable of producing tissue factor (TF).
- These progenitor cells possess functional TF, contributing to procoagulant activity.
- The presence of TF mRNA confirms the synthesis of TF at the molecular level in these cells.
Related Concept Videos
Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Production of Formed Elements
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
Structure and Function of Platelets
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

